Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Genomics and its application in crop improvement.J Pharmacognosy Phytochemistry. 2020; 9: 547-552
- Development application polymerase chain reaction (PCR).J Am Sci. 2005; 1: 1-15
- Ten years of next-generation sequencing technology.Trends Genetics. 2014; 30: 418-426
- Clinical applications of next-generation sequencing in precision oncology.Cancer J. 2019; 25: 264-271
- Whole cancer genome sequencing by next-generation methods.Am J Clin Pathol. 2011; 136: 527-539
- Genomic medicine: a practical guide.Springer, New York2019
- Molecular platforms utilized to detect BRAF V600E mutation in melanoma.. 2012; 31: 267-273
- Molecular biomarkers for lung adenocarcinoma.Eur Respir J. 2017; 49https://doi.org/10.1183/13993003.01734-2016
- Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond.Transplant Lung Cancer Res. 2015; 4: 126-141
- Analysis of any point mutation in DNA. the amplification refractory mutation system (ARMS).Nucleic Acids Res. 1989; 17: 2503-2516
- Allele-specific polymerase chain reaction for the detection of alzheimer’s disease-related single nucleotide polymorphisms.BMC Med Genet. 2013; 14: 1-8
- An overview of molecular genetic diagnosis techniques.Curr Protoc Hum Genet. 2020; 105: e97
- High-resolution melting curve analysis for molecular diagnostics.in: Patrinos G.P. Molecular diagnostics. Elsevier, Philadelphia2017: 79-102
- DNA fragment analysis by capillary electrophoresis. Carlsbad: Thermo FIsher Sicentific.Inc. 2014;
- The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia.Leuk Res Rep. 2020; 13: 100198
- 4MO MET exon 14 screening strategy: how not to miss large deletions.Ann Oncol. 2020; 31: S1218
- Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length.Blood Cancer J. 2015; 5: e336
- Comparative study of BCR-ABL1 quantification: xpert assay, a feasible solution to standardization concerns.Ann Hematol. 2012; 91: 1245-1250
- Molecular pathology of colorectal cancer.Adv Anat Pathol. 2020; 27: 20-26
- Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the idylla technique with high-throughput next-generation sequencing.J Clin Pathol. 2020; 73: 35-41
- Evaluation, validation, and implementation of the idylla system as rapid molecular testing for precision medicine.J Mol Diagn. 2019; 21: 862-872
- Comparison of tissue molecular biomarker testing turnaround times and concordance between standard of care and the biocartis idylla platform in patients with colorectal cancer.Am J Clin Pathol. 2020; 154: 266-276
- Evaluation of xpert® BCR-ABL ultra for the confirmation of BCR-ABL1 international scale conversion factors for the molecular monitoring of chronic myeloid leukaemia.Int J Lab Hematol. 2021; 43: e31-e34
- Evaluation of the cepheid GeneXpert BCR-ABL assay.J Mol Diagn. 2007; 9: 220-227
- Next-generation sequencing in clinical practice: is it a cost-saving alternative to a single-gene testing approach?.PharmacoEconomics-Open. 2021; 5: 285-298
- How far do we go with genetic evaluation? gene, panel, and tumor testing.Am Soc Clin Oncol Educ Book. 2016; 36: e72-e78
- Building a robust tumor profiling program: synergy between next-generation sequencing and targeted single-gene testing.PloS one. 2016; 11: e0152851
- When should we order a next generation sequencing test in a patient with cancer?.EClinicalMedicine. 2020; 25: 100487
- Detection of targetable genetic alterations in Korean lung cancer patients: a comparison study of single-gene assays and targeted next-generation sequencing.Cancer Res Treat. 2020; 52: 543-551
- Economic analysis of BRAF gene mutation testing in real world practice using claims data: costs of single gene versus panel tests in patients with lung cancer.J Med Econ. 2018; 21: 649-655
- 454 next generation-sequencing outperforms allele-specific PCR, sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.Onco Targets Ther. 2013; 6: 1057-1064
- Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel.Diagnostics. 2020; 10: 250
- Rapid EGFR mutation detection using the idylla platform: single-institution experience of 1200 cases analyzed by an in-house developed pipeline and comparison with concurrent next-generation sequencing results.J Mol Diagn. 2021; 23: 310-322
- Economic impact of next-generation sequencing versus single-gene testing to detect genomic alterations in metastatic non–small-cell lung cancer using a decision analytic model.JCO Precision Oncol. 2019; 3: 1-9
- Utility of incorporating next-generation sequencing (NGS) in an asian non-small cell lung cancer (NSCLC) population: incremental yield of actionable alterations and cost-effectiveness analysis.Lung Cancer. 2020; 139: 207-215
- The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice.Blood J Am Soc Hematol. 2017; 130: 433-439
- Do more with less: Tips and techniques for maximizing small biopsy and cytology specimens for molecular and ancillary testing: the university of Colorado experience.Arch Pathol Lab Med. 2016; 140: 1206-1220
- Cytology smears in the era of molecular biomarkers in non–small cell lung cancer: doing more with less.Arch Pathol Lab Med. 2018; 142: 291-298
- Cytology samples and molecular biomarker testing in lung cancer—advantages and challenges.Virchows Archiv. 2021; : 1-13
- Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.J Thorac Oncol. 2011; 6: 1849-1856
- Biomarker testing in lung carcinoma cytology specimens: a perspective from members of the pulmonary pathology society.Arch Pathol Lab Med. 2016; 140: 1267-1272
- Competitive allele-specific TaqMan PCR (cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in melanoma patients.Sci Rep. 2015; 5: 1-11
- Molecular pathogenesis of IDH mutations in gliomas.Brain Tumor Pathol. 2012; 29: 131-139
- IDH mutations in glioma and acute myeloid leukemia.Trends Mol Med. 2010; 16: 387-397
- A novel Cas9-targeted long-read assay for simultaneous detection of IDH1/2 mutations and clinically relevant MGMT methylation in fresh biopsies of diffuse glioma.Acta Neuropathol Commun. 2020; 8: 1-13
- A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.Acta neuropathologica Commun. 2014; 2: 1-12
- Diagnostic testing for IDH1 and IDH2 variants in acute myeloid leukemia: an algorithmic approach using high-resolution melting curve analysis.J Mol Diagn. 2011; 13: 678-686
- A longitudinal evaluation of performance of automated BCR-ABL1 quantitation using cartridge-based detection system.Pathology. 2015; 47: 570-574
- New approaches to molecular monitoring in CML (and other diseases).Blood. 2019; 134: 1578-1584
Article info
Publication history
Published online: August 22, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
